The Biotech Brief brings you clear, concise updates on the most impactful developments in biotechnology, precision medicine, and life science innovation. Produced by The HEII (Hub for Empowering Impactful Initiatives), this podcast breaks down clinical trial wins, regulatory shifts, and emerging therapeutic strategies in a format designed for busy scientists, entrepreneurs, investors, and changemakers. If you’re new to following the industry, this podcast is also for you. Stay informed. Stay inspired. Stay briefed.
All content for The Biotech Brief is the property of The HEII and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Biotech Brief brings you clear, concise updates on the most impactful developments in biotechnology, precision medicine, and life science innovation. Produced by The HEII (Hub for Empowering Impactful Initiatives), this podcast breaks down clinical trial wins, regulatory shifts, and emerging therapeutic strategies in a format designed for busy scientists, entrepreneurs, investors, and changemakers. If you’re new to following the industry, this podcast is also for you. Stay informed. Stay inspired. Stay briefed.
Gilead’s twice-yearly injectable PrEP, Yeztugo was recently approved by the FDA, but the story doesn’t end there. In this episode of The Biotech Brief, we explore how Gilead is leveraging global partnerships, generics, and regulatory streamlining to deliver Yeztugo to low- and middle-income countries without delay. Building on Episode 1, “Changing the Game in HIV Prevention,” this follow-up digs into what equitable access really takes and what drug developers can learn from it.
The Biotech Brief
The Biotech Brief brings you clear, concise updates on the most impactful developments in biotechnology, precision medicine, and life science innovation. Produced by The HEII (Hub for Empowering Impactful Initiatives), this podcast breaks down clinical trial wins, regulatory shifts, and emerging therapeutic strategies in a format designed for busy scientists, entrepreneurs, investors, and changemakers. If you’re new to following the industry, this podcast is also for you. Stay informed. Stay inspired. Stay briefed.
